Is Privia Health Stock a Buy After Hedge Fund Rubicon Founders Added Over 175,000 Shares to Its Position? Privia Health Group delivers technology-driven solutions to optimize physician practices and support value-based care nationwide.
What to Know About This Fund's $74.8 Million Indivior Sale Indivior develops buprenorphine-based treatments for opioid dependence, serving markets in the US, UK, and worldwide.
This Wealth Advisor Just Reduced a Maturing Bond Fund. Here's How Target-Maturity ETFs Actually Work. This ETF targets investment grade corporate bonds maturing in 2026, aiming to deliver predictable income and a defined maturity date.
3 Space Stocks Flying Under the Radar and Worth Buying This Month As the space industry rockets upward, a few companies shouldn't be left behind by investors.
Why Wall Street Is Dead Wrong About This Popular Stock Often, investors and Wall Street analysts focus on the short term and don't give enough thought to the long term.
These Artificial Intelligence (AI) Stocks Have Crushed Nvidia in 2026 With Gains of 67% and 121%. They Can Still Soar Higher Lumentum Holdings and Applied Materials are important players in the AI infrastructure space, which explains why their stock prices have been soaring this year.
Bloom Energy vs. Plug Power: Which Hydrogen Stock Is a Better Buy in 2026? Between Bloom Energy and Plug Power, one company is generating positive cash flows and growing its revenue at a torrid pace.
Why a Fund Made a $143 Million Bet on Indivior With Shares Up a Staggering 200% Indivior develops buprenorphine-based therapies for opioid dependence, serving healthcare providers and treatment centers worldwide.
NASA And UFO ETFs Are Surging Ahead Of SpaceX IPO But Key Risks Remain Top space ETFs like NASA and UFO have surged and are seeing strong inflows this year ahead of the SpaceX IPO but risks remain.
Why This Fund Made a $30 Million Bet on Floor & Decor Amid a 30% Stock Drop Floor & Decor supplies hard surface flooring and installation products to professional installers and DIY customers across the U.S.
Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More Vericel develops cell therapies for cartilage repair and burn care, serving hospitals and clinics across the United States.
1 AI Stock That Could Turn $500 per Month Into $1 Million Nebius could become one of the biggest long-term winners in the current disciplined phase of AI infrastructure spending.
Wix Stock Has Crashed This Past Year, and One Investor Exited a $4.35 Million Position Wix.com Ltd. delivers cloud-based website creation and business management tools to a global client base through a subscription model.
What to Know About a New $18 Million Bet on Cal-Maine Foods Cal-Maine Foods is a leading U.S. producer of shell eggs and specialty varieties for major grocery and foodservice customers nationwide.
